TomoTherapy to Present at Oppenheimer Healthcare Conference

Business Wire, Oct 27, 2008

MADSION, Wis. -- TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Dr. Fred Robertson, CEO, and Steve Hathaway, CFO, will present at the Oppenheimer 19th Annual Healthcare Conference on Monday, November 3, 2008 at 3:20 p.m., ET. The conference is scheduled for November 3-4 at the Waldorf-Astoria Hotel in New York City.

Robertson and Hathaway will address investors, portfolio managers and analysts.

A live Webcast of this presentation will be available on the Investor Relations page of TomoTherapy.com. An archive of the Webcast will also be available on the company's site for 30 days following the presentation.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy([R]) HioArt([R]) treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The HioArt treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

[c]2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and HioArt are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.